LCM
AEGR

Landscape Capital Management’s Aegerion Pharmaceuticals AEGR Stock Holding History

Landscape Capital Management’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-76,554
Closed -$773K – 1028
2015
Q4 		$773K Buy
+76,554
New +$921K 0.1% 280
2015
Q1 		– Sell
-13,000
Closed -$272K – 781
2014
Q4 		$272K Buy
+13,000
New +$328K 0.13% 302
2014
Q3 		– Sell
-9,600
Closed -$308K – 467
2014
Q2 		$308K Buy
+9,600
New +$357K 0.21% 127

Other funds holding AEGR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Landscape Capital Management's AEGR Position: Q1 2016 in Review

Landscape Capital Management sold out of Aegerion Pharmaceuticals (AEGR) in Q1 2016, closing a stake of 76,554 shares — an estimated $773K sold.

Landscape Capital Management first reported a position in AEGR in Q2 2014 and held it in 3 quarters. The position peaked at $773K in Q4 2015. 101 funds tracked by Wall St. Rank hold AEGR as of Q1 2016.

  • Landscape Capital Management reported no remaining Aegerion Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Landscape Capital Management sold 76,554 Aegerion Pharmaceuticals shares in Q1 2016, an estimated $773K.
  • Landscape Capital Management first reported a position in Aegerion Pharmaceuticals in Q2 2014 and held it in 3 quarters.
  • Landscape Capital Management's Aegerion Pharmaceuticals position peaked at $773K in Q4 2015.
  • 101 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q1 2016.

Based on Landscape Capital Management's 13F filing for Q1 2016, filed 11 May 2016.